Complement activation in patients with neuromyelitis optica.

Complement activation in patients with neuromyelitis optica.

Afficher d'autres versions (1)

The role of complement has been demonstrated in experimental models of neuromyelitis optica (NMO), however, only few studies have analysed complement components longitudinally in NMO patients. We measured serum or plasma concentrations of anti-C1q antibodies and complement split products C3a and C4a...

Description complète

Détails bibliographiques
Auteurs principaux:	Nytrova, P, Potlukova, E, Kemlink, D, Woodhall, M, Horakova, D, Waters, P, Havrdova, E, Zivorova, D, Vincent, A, Trendelenburg, M
Format:	Journal article
Langue:	English
Publié:	2014

Documents similaires

Complement activation in patients with neuromyelitis optica
par: Nytrova, P, et autres
Publié: (2014)

C3a complement split product: possible biomarker of disease activity in patients with neuromyelitis optica
par: Nytrova, P, et autres
Publié: (2013)

Intra-cerebral injection of neuromyelitis optica immunoglobulin G and human complement produces neuromyelitis optica lesions in mice.
par: Saadoun, S, et autres
Publié: (2010)

Multicentre comparison of a diagnostic assay: aquaporin-4 antibodies in neuromyelitis optica
par: Waters, P, et autres
Publié: (2016)

IgG subclasses of disease-specific antibodies and complement activation in-vitro in seronegative myasthenia gravis and neuromyelitis optica
par: Jacob, S, et autres
Publié: (2008)

Myelin-oligodendrocyte glycoprotein antibodies in adults with a neuromyelitis optica phenotype.
par: Kitley, J, et autres
Publié: (2012)

Immunological insights into the mechanisms by which RTX is effective in Neuromyelitis Optica spectrum disorders
par: Damato, V, et autres
Publié: (2019)

Glycine receptor and myelin oligodendrocyte glycoprotein antibodies in Turkish patients with neuromyelitis optica.
par: Woodhall, M, et autres
Publié: (2013)

Aquaporin-4 Antibody Isoform Binding Specificity Does Not Explain Clinical Variations in Neuromyelitis Optica
par: Kitley, J, et autres
Publié: (2013)

The impact of neuromyelitis optica spectrum disorder on pregnancy outcome
par: Nour, M, et autres
Publié: (2014)

Paediatric neuromyelitis optica: clinical, MRI of the brain and prognostic features.
par: Absoud, M, et autres
Publié: (2014)

Neuromyelitis optica relapses: race and rate, immunosuppression and impairment
par: Tackley, G, et autres
Publié: (2016)

Myelin-oligodendrocyte glycoprotein antibody-mediated acute inflammatory demyelinating disease mimicking neuromyelitis optica
par: Kitley, J, et autres
Publié: (2011)

Novel Anti-Neuronal Antibodies in Neuromyelitis Optica Patients with or without Aquaporin-4 Antibodies
par: Cavus, F, et autres
Publié: (2013)

Methotrexate is an alternative to azathioprine in neuromyelitis optica spectrum disorders with aquaporin-4 antibodies
par: Kitley, J, et autres
Publié: (2013)

Methotrexate is an alternative to azathioprine in neuromyelitis optica spectrum disorders with aquaporin-4 antibodies.
par: Kitley, J, et autres
Publié: (2013)

Symptomatic brain involvement as the initial manifestation of neuromyelitis optica.
par: Min, J, et autres
Publié: (2013)

Alternative antigen targets in aquaporin-4 antibodynegative neuromyelitis optica spectrum disorders
par: Kitley, J, et autres
Publié: (2013)

Neuromyelitis optica in patients with gluten sensitivity associated with antibodies to aquaporin-4.
par: Jarius, S, et autres
Publié: (2008)

IgG subclasses of disease-specific antibodies and complement activation in vitro in myasthenia gravis and neuromyelitis optica
par: Jacob, S, et autres
Publié: (2007)

Utility of aquaporin-4 antibody assay in patients with neuromyelitis optica spectrum disorders.
par: Kim, S, et autres
Publié: (2013)

Antibodies to aquaporin-1 are not present in neuromyelitis optica
par: Waters, P, et autres
Publié: (2015)

Mechanisms of disease: aquaporin-4 antibodies in neuromyelitis optica.
par: Jarius, S, et autres
Publié: (2008)

Complement activating antibodies to myelin oligodendrocyte glycoprotein in neuromyelitis optica and related disorders
par: Mader Simone, et autres
Publié: (2011-12-01)

MYELIN-OLIGODENDROCYTE GLYCOPROTEIN ANTIBODY AS A CAUSE OF ACUTE DISSEMINATED ENCEPHALOMYELITIS WITH A NEUROMYELITIS OPTICA-LIKE PHENOTYPE IN ADULTS
par: Kitley, J, et autres
Publié: (2012)

Symptomatic, radiological and pathological involvement of the hypothalamus in neuromyelitis optica.
par: Viegas, S, et autres
Publié: (2009)

Prognostic implications of aquaporin-4 antibody status in neuromyelitis optica patients.
par: Akman-Demir, G, et autres
Publié: (2011)

Detection of anti-aquaporin-4 antibodies in neuromyelitis optica: current status of the assays.
par: Waters, P, et autres
Publié: (2008)

Characterization of neuromyelitis optica and neuromyelitis optica spectrum disorder patients with a late onset.
par: Collongues, N, et autres
Publié: (2013)

Effect of IgG from seronegative and seropositive neuromyelitis optica patients on mouse brain
par: Saadoun, S, et autres
Publié: (2013)

Neuromyelitis Optica
par: Goyal V, et autres
Publié: (2009-10-01)

Neuromyelitis optica
par: Jacob Anu, et autres
Publié: (2007-01-01)

Neuromyelitis Optica Spectrum Disorders With Aquaporin-4 and Myelin-Oligodendrocyte Glycoprotein Antibodies A Comparative Study
par: Kitley, J, et autres
Publié: (2014)

Neuromyelitis optica spectrum disorders with aquaporin-4 and myelin-oligodendrocyte glycoprotein antibodies: a comparative study.
par: Kitley, J, et autres
Publié: (2014)

Sex bias in multiple sclerosis and neuromyelitis optica spectrum disorders: How it influences clinical course, MRI parameters and prognosis
par: Petra Nytrova, et autres
Publié: (2022-08-01)

Complement biomarkers reflect the pathological status of neuromyelitis optica spectrum disorders
par: Katsuichi Miyamoto, et autres
Publié: (2023-03-01)

Neuromyelitis optica IgG causes placental inflammation and fetal death.
par: Saadoun, S, et autres
Publié: (2013)

Rituximab abrogates aquaporin-4-specific germinal center activity in patients with neuromyelitis optica spectrum disorders
par: Damato, V, et autres
Publié: (2022)

Anti-MOG Antibodies in Japanese Patients with Neuromyelitis Optica Spectrum Disorders
par: Sato, D, et autres
Publié: (2014)

Cell-based assay for anti-AQP4 antibody in Korean patients with neuromyelitis optica
par: Kim, B, et autres
Publié: (2010)